Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research
Project Number5U01IP000474-03
Contact PI/Project LeaderMONTO, ARNOLD S
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
DESCRIPTION (provided by applicant): Because of near universal recommendation for annual vaccination (all aged 6 months) only observational studies of influenza vaccine effectiveness can be performed for ethical reasons. However, results from observational studies may be subject to unrecognized selection biases, and study design strategies to identify and adjust for these biases are necessary. We propose estimation of influenza vaccine effectiveness in preventing medically attended influenza in two health systems, and influenza of all severities in a cohort of households with children, in Michigan. We will conduct surveillance at multiple outpatient health centers, three hospitals, and in ~300 enrolled households during the influenza season, and will enroll adult and pediatric patients and household members meeting various case definitions. Vaccination status will be reported and validated, and considered with laboratory-confirmed influenza outcomes to estimate vaccine effectiveness separately for ambulatory, inpatient and household populations, with estimates compared across studies. Analyses will use a test-negative control approach-those testing positive for influenza are cases, those testing negative are controls. Modifiers and confounders of vaccine effectiveness such as age, health status, household size and composition, health care utilization, subjective socio-economic status, and health system characteristics will be assessed and considered in analytic models.
Public Health Relevance Statement
Relevance: MFIVE-HIVE combined
Annual estimation of influenza vaccine effectiveness is necessary to guide vaccination and
control policy. We propose estimation of influenza vaccine effectiveness in preventing medically
attended influenza among patients in two health systems, and influenza of all severities in a
cohort of households with children, in Michigan. Laboratory confirmed influenza outcomes and
verified influenza vaccination status will be used to calculate vaccine effectiveness using a test-
negative control approach.
National Center for Immunization and Respiratory Diseases
CFDA Code
185
DUNS Number
073133571
UEI
GNJ7BBP73WE9
Project Start Date
01-July-2011
Project End Date
30-June-2016
Budget Start Date
01-July-2013
Budget End Date
30-June-2014
Project Funding Information for 2013
Total Funding
$1,085,000
Direct Costs
$757,708
Indirect Costs
$327,292
Year
Funding IC
FY Total Cost by IC
2013
National Center for Immunization and Respiratory Diseases
$1,085,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01IP000474-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01IP000474-03
Patents
No Patents information available for 5U01IP000474-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01IP000474-03
Clinical Studies
No Clinical Studies information available for 5U01IP000474-03
News and More
Related News Releases
No news release information available for 5U01IP000474-03
History
No Historical information available for 5U01IP000474-03
Similar Projects
No Similar Projects information available for 5U01IP000474-03